Skip to main content
. 2017 Jan 16;3(1):e000395. doi: 10.1136/rmdopen-2016-000395

Figure 1.

Figure 1

Kaplan–Meier survival curve showing time to loss of clinical benefit after TNFi discontinuation (N=325). LDA, low disease activity; TNFi, tumour necrosis factor inhibitor.